Ibrahim, Raihan .

HRN: 08-39-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
METRONIDAZOLE 500MG (TAB)
10/25/2023
11/01/2023
ORAL
500mg
TID
AGE; Dengue Fever
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamIntra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: